As of mid-2025, retatrutide remains in Phase 3 clinical development for obesity, type 2 diabetes, and metabolic liver disease
A single, highly specific LPS receptor was presumed to exist as early as the 1960s, based on the fact that allelic mutations in two separate strains of mice, affecting a discrete genetic locus on chromosome 4 termed Lps , abolished LPS sensing
The results of this case series suggest that oral glutathione supplementation may improve oxidative markers, but this does not necessarily translate to the observed clinical improvement of subjects with ASD
Instead of escalating to higher doses, microdosing focuses on using the lowest effective amount to help regulate hunger, improve metabolic response, and support steady, sustainable weight loss